Skip to main content
https://www.highperformancecpmgate.com/rgeesizw1?key=a9d7b2ab045c91688419e8e18a006621

Caribou Biosciences CEO, Rachel Haurwitz will talk CRISPR’s present and future applications at DisruptSF

Seven years ago, Rachel Haurwitz finished her last day as a student in the University of California laboratory where she helped conduct some of the pioneering research on the gene editing technology known as CRISPR, and became employee number one at Caribou Biosciences, a company founded to commercialize that research.

In those seven years, the market for CRISPR applications has grown tremendously and Caribou Biosciences is at the forefront of the companies propelling it forward. 

Which is why we’re absolutely thrilled to have Haurwitz join us on stage at Disrupt SF 2019.

Haurwitz studied under Caribou Biosciences’ co-founder Jennifer Doudna — one of the scientists who discovered CRISPR’s gene editing applications — and Caribou was formed to be the conduit through which the groundbreaking research from the Berkeley lab would become products that companies could use.

Short for “Clustered Regularly Interspaced Short Palindromic Repeats”, CRISPR works by targeting certain sequences of DNA — the genetic instructions for the development and reproduction of all organisms — and then binding them to an enzyme that cuts the specific sequence.

Once edited, researchers can add or simply delete pieces of genetic material, or change the DNA by replacing a segment with customized code designed to achieve specific functions.

There are few industries that CRISPR doesn’t have the power to transform. Already, Caribou Biosciences technology is being used at Intellia, which is developing therapies based on CRISPR technologies (Haurwitz is a co-founder). And that’s just the beginning.

Caribou’s chief executive thinks of her company as a platform for developing technologies in therapeutics, research, agriculture and industrial biology.

Already, CRISPR technologies are being used to biologically manufacture chemicals, replace pesticides and fertilizers, and provide cures for rare diseases once though impossible.

“Any market with bio-based products will be changed by gene editing,” Haurwitz has said.

At SF Disrupt Haurwitz will talk about the implications of that transformation, and what’s ahead for the company that’s leading the charge in this genetic revolution.

Tickets are available here.

Comments

Post a Comment

Popular posts from this blog

Uber co-founder Garrett Camp steps back from board director role

Uber co-founder Garrett Camp is relinquishing his role as a board director and switching to board observer — where he says he’ll focus on product strategy for the ride hailing giant. Camp made the announcement in a short Medium post in which he writes of his decade at Uber: “I’ve learned a lot, and realized that I’m most helpful when focused on product strategy & design, and this is where I’d like to focus going forward.” “I will continue to work with Dara [Khosrowshahi, Uber CEO] and the product and technology leadership teams to brainstorm new ideas, iterate on plans and designs, and continue to innovate at scale,” he adds. “We have a strong and diverse team in place, and I’m confident everyone will navigate well during these turbulent times.” The Canadian billionaire entrepreneur signs off by saying he’s looking forward to helping Uber “brainstorm the next big idea”. Camp hasn’t been short of ideas over his career in tech. He’s the co-founder of the web 2.0 recommendatio...
Post a Comment
Read more

Drone crash near kids leads Swiss Post and Matternet to suspend autonomous deliveries

A serious crash by a delivery drone in Switzerland have grounded the fleet and put a partnership on ice. Within a stone’s throw of a school, the incident raised grim possibilities for the possibilities of catastrophic failure of payload-bearing autonomous aerial vehicles. The drones were operated by Matternet as part of a partnership with the Swiss Post (i.e. the postal service), which was using the craft to dispatch lab samples from one medical center for priority cases. As far as potential applications of drone delivery, it’s a home run — but twice now the craft have crashed, first with a soft landing and the second time a very hard one. The first incident, in January, was the result of a GPS hardware error; the drone entered a planned failback state and deployed its emergency parachute, falling slowly to the ground. Measures were taken to improve the GPS systems. The second failure in May, however, led to the drone attempting to deploy its parachute again, only to sever the line...
Post a Comment
Read more

How the world’s largest cannabis dispensary avoids social media restrictions

Planet 13 is the world’s largest cannabis dispensary. Located in Las Vegas, blocks off the Strip, the facility is the size of a small Walmart. By design, it’s hard to miss. Planet 13 is upending the dispensary model. It’s big, loud and visitors are encouraged to photograph everything. As part of the cannabis industry, Planet 13 is heavily restricted on the type of content it can publish on Instagram, Facebook and other social media platforms. It’s not allowed to post pictures of buds or vapes on some sites. It can’t talk about pricing or product selection on others.   View this post on Instagram   A post shared by Morgan Celeste SF Blogger (@bayareabeautyblogger) on Jan 25, 2020 at 7:54pm PST Instead, Planet 13 encourages its thousands of visitors to take photos and videos. Starting with the entrance, the facility is full of surprises tailored for the ‘gram. As a business, Planet 13’s social media content is heavily restricted a...
3 comments
Read more